A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2004
12/07/2004	US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828326 Pyrimidinone fused bicyclic metalloproteinase inhibitors
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828312 Therapy of mammal susceptible to, suffering from, suspected of having or recovering from a disease impacted by tissue factor(TF), by administering TF blocking compound
12/07/2004	US6827945 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/02/2004	WO2004104015A2 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
12/02/2004	WO2004104000A1 Tricyclic condensed ring compound and medical use thereof
12/02/2004	WO2004103974A1 Substituted 2-oxoquinoline compound and medicinal use thereof
12/02/2004	WO2004103955A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
12/02/2004	WO2004103954A1 Amide derivative
12/02/2004	WO2004103946A1 Carboxylic acid compound and medicine containing the same
12/02/2004	WO2004071389A3 Non-steroidal infalmmation inhibitors
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	US20040243097 Antiproliferative drug and delivery device
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242872 Method of preparing 4-(imidazole-1-yl)benzenesulphonamide derivatives
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242851 Immunoglobulin specifiic for vascular endothelial growth factor receptor for use in treatment and prevention of tumor; angiogenesis inhibitors; antitumor agents; antimetastasis agents; immunotherapy
12/02/2004	US20040242685 Administering -4-benzyloxy-3,5-dimethoxy-N-[(1-dimethylaminocyclopentyl)methyl]benzamide or derivatives for treating disorders responsive to inhibition of the GlyT-2 transporter, such as muscle spasticity, epilepsy and acute, chronic and neuropathic pain
12/02/2004	US20040242663 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
12/02/2004	US20040242657 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242654 Diaryl ether derivative, addition salt thereof, and immunosuppressant
12/02/2004	US20040242641 Nicotinic acetylcholine receptors to treat pain
12/02/2004	US20040242640 Dual-release compositions of a cyclooxygenase-2 inhibitor
12/02/2004	US20040242637 drugs used for signal transduction modulation, and for prophylaxis of angiogenesis, cancers, tumors, atherosclerosis, vision disorders and inflammatory diseases in mammals
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242598 Phosphodiesterase 4 inhibitors
12/02/2004	US20040242597 Combination
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242573 Novel compounds
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242558 Pyridylether derivatives, their preparation and use
12/02/2004	US20040242491 For use in the treatment of gout and related symptoms or in the amelioration of symptoms related to a high level of uric acid such as muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, or as a dietary supplement
12/02/2004	US20040242459 Method for treating inflammatory diseases by administering a ppar-delta agonist
12/02/2004	US20040241818 Assay
12/02/2004	US20040241805 Cell surface binding protein for use in treatment, diagnosis and prevention of cancer, inflammation, autoimmunity, allergy, asthma and nervous system disorders
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241232 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/02/2004	US20040241204 Sustained release pharmaceutical composition
12/02/2004	US20040241176 Method of producing membrane vesicles
12/02/2004	US20040241159 Serotonin receptor antagonists, analgesic (aspirin), and antiemitic; treating cephalic pain such as migraine, cluster headache, chronic paroxysmal hermicrania, headache associated with vascular disorders, headache associated with substances or their withdrawl, rebound headache and tension headache
12/02/2004	US20040241149 prevention or prophylaxis of inflammatory condition comprising administering lactic acid bacteria containing unmethylated cytosine-guanine (cpg) dinucleotide to modulate the cytokine response of human or animal immune system; antiinflammatory agents
12/02/2004	CA2526637A1 Carboxylic acid compound and medecine comprising the same
12/02/2004	CA2517490A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
12/02/2004	CA2469528A1 Peptide and peptide mimetic derivatives having integrin inhibitor properties iii
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481685A1 Use of PAM
12/01/2004	EP1481680A1 Use of S1P
12/01/2004	EP1481250A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/01/2004	EP1481243A1 Therapeutic properties of oils
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1481067A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
12/01/2004	EP1481010A2 Anti-interleukin-1 beta analogs
12/01/2004	EP1480996A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
12/01/2004	EP1480993A2 Desaturase genes, enzymes encoded thereby, and uses thereof
12/01/2004	EP1480980A2 Syntheses of quinazolinones
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480971A1 Isoquinoline derivatives
12/01/2004	EP1480964A1 Inhibiteurs de l'angiogenese
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480948A1 Semicarbazide derivatives and their use as antithrombotics
12/01/2004	EP1480946A2 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity
12/01/2004	EP1480688A1 N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents
12/01/2004	EP1480678A2 Treatment of ophthalmic disorders using urea and urea derivatives
12/01/2004	EP1480655A2 Dna demethylase antisense and chemotherapy combination
12/01/2004	EP1480639A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
12/01/2004	EP1480630A1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa
12/01/2004	EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480603A1 Use of sugar esters in cosmetic and/or pharmaceutical preparations
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480595A2 Use of esters of long-chain fatty acids for treatment of autoimmune diseases
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists

1 ... 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 ... 1272